Evidence map›Paper›PMID 26900405›Full record

ArticleGut pathogens2016

Genomic characterization and assessment of the virulence and antibiotic resistance of the novel species Paenibacillus sp. strain VT-400, a potentially pathogenic bacterium in the oral cavity of patients with hematological malignancies.

George Tetz, Victor Tetz, Maria Vecherkovskaya

Abstract read
In one paragraph

Article in Gut pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Tetz's theory and law of longevity.Theory in biosciences = Theorie in den Biowissenschaften · 2018
    Article
  6. Review
  7. Article
  8. Draft Genome Sequence ofGenome announcements · 2018
    Article
  9. Draft Genome Sequence ofGenome announcements · 2018
    Article
  10. Complete Genome Sequence ofGenome announcements · 2017
    Article
  11. Draft Genome Sequence of a Strain ofGenome announcements · 2017
    Article
  12. Draft Genome Sequence of the UropathogenicGenome announcements · 2017
    Article
  13. Draft Genome Sequence ofGenome announcements · 2017
    Article
  14. Draft Genome Sequence ofGenome announcements · 2017
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

George TetzInstitute of Human Microbiology, LLC, 303 5th Avenue, Suite 2012, New York, NY 10016 USA.ORCID 0000-0003-3205-9018
Victor TetzFirst State I. P. Pavlov Medical University, Lev Tolstoy Str. 6/8, Saint Petersburg, Russia 197022.
Maria VecherkovskayaFirst State I. P. Pavlov Medical University, Lev Tolstoy Str. 6/8, Saint Petersburg, Russia 197022.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPaenibacillus sp. strain VT-400, a novel spore-forming bacterium, was isolated from patients with hematological malignancies.

methodsPaenibacillus sp. strain VT-400 was isolated from the saliva of four children with acute lymphoblastic leukemia. The genome was annotated using RAST and the NCBI Prokaryotic Genome Annotation Pipeline to characterize features of antibiotic resistance and virulence factors. Susceptibility to antibiotics was determined by the Kirby-Bauer disc diffusion method. We used a mouse model of pneumonia to study virulence in vivo. Mice were challenged with 7.5 log10-9.5 log10 CFU, and survival was monitored over 7 days. Bacterial load was measured in the lungs and spleen of surviving mice 48 h post-infection to reveal bacterial invasion and dissemination.

resultsWhole-genome sequencing revealed a large number of virulence factors such as hemolysin D and CD4+ T cell-stimulating antigen. Furthermore, the strain harbors numerous antibiotic resistance genes, including small multidrug resistance proteins, which have never been previously found in the Paenibacillus genus. We then compared the presence of antibiotic resistance genes against results from antibiotic susceptibility testing. Paenibacillus sp. strain VT-400 was found to be resistant to macrolides such as erythromycin and azithromycin, as well as to chloramphenicol and trimethoprim-sulphamethoxazole. Finally, the isolate caused mortality in mice infected with ≥8.5 log10 CFU.

conclusionsBased on our results and on the available literature, there is yet no strong evidence that shows Paenibacillus species as an opportunistic pathogen in immunocompromised patients. However, the presence of spore-forming bacteria with virulence and antibiotic resistance genes in such patients warrants special attention because infections caused by spore-forming bacteria are poorly treatable.

Indexed as

Antibiotic resistanceHematological malignanciesImmunocompromisedNosocomialPaenibacillus sp.PathogenPneumonia

Identifiers

PMID26900405
PMCPMC4761199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.